Biocon trades higher on the BSE

10 Nov 2023 Evaluate

Biocon is currently trading at Rs. 228.30, up by 1.20 points or 0.53% from its previous closing of Rs. 227.10 on the BSE.

The scrip opened at Rs. 227.55 and has touched a high and low of Rs. 228.75 and Rs. 222.55 respectively. So far 129892 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 293.30 on 21-Nov-2022 and a 52 week low of Rs. 191.60 on 21-Mar-2023.

Last one week high and low of the scrip stood at Rs. 229.95 and Rs. 222.55 respectively. The current market cap of the company is Rs. 26995.49 crore.

The promoters holding in the company stood at 60.64%, while Institutions and Non-Institutions held 22.05% and 17.32% respectively.

Biocon’s subsidiary -- Biocon Biologics has divested the businesses in relation to its non-core branded formulations in India, comprising, inter alia, of generic dermatology and nephrology small molecule formulations (BFI Non-Core Business) to Eris Lifesciences on a ‘slump sale’ basis. Consideration received from such sale/disposal is Rs 366 crore including working capital adjustments. 

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

316.15 -4.65 (-1.45%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.